Information on Quercetin and its Benefits

A bioflavonoid, which is becoming increasingly popular, quercetin serves as a backbone for other flavonoids and is considered to be the most active of them all. Quercetin has a wide range of beneficial effects. It has been found to be a powerful antioxidant, neutralizes free radicals, which are the underlying causes of the degenerative diseases of ageing such as heart disease, cancer and arthritis; it has also been reported to possess strong and prolonged anti-inflammatory and wound healing properties. In addition, it is reported to be effective against viruses, especially oral herpes.

Quercetin has also been shown to have anti-cancer properties and studies have revealed that if can inhibit the proliferation of maligant cells in breast and ovarian cancers and leukemia. It has also been found to inhibit histamine release, making it useful in the treatment of allergies. Additional studies have reported on the ability of quercetin to delay the onset of cataract, and, since it is able to enhance insulin secretion, it is also useful in the control of diabetes.

Quercetin is abundant in fruits and vegetables such as citrus rind, garlic, onions and blue-green algae and supplements of quercetin are now available in health food shops in capsule form.

Caution: High doses of quercetin supplements may cause diarrhea.

Leave your comments

Health News

Surgeon Removes Eight Pound Liver Tumor

The cancerous tumor in Marcus Muhich's liver weighed 8 pounds and was nearly a foot across. Doctors at three major academic medical centers in the Midwest told Muhich his high-grade tumor was inoperable. Then he was referred to Dr... [ read article ]

NIPPV Linked To Increased Hospital Mortality Rates In Small Group Of Patients

Although increased use of noninvasive positive-pressure ventilation (NIPPV) nationwide has helped decrease mortality rates among patients hospitalized with chronic obstructive pulmonary disease (COPD), a small group of... [ read article ]

FDA Approves Label Update For PREZISTA® To Include 192-Week Data In HIV-1-Infected Adult Patients

Starting Treatment Janssen Therapeutics, Division of Janssen Products, LP, announced that the U.S. Food and Drug Administration (FDA) has approved a label update for PREZISTA® (darunavir) tablets to include 192-week data from the ARTEMIS study... [ read article ]

Recommended Stuff

Our Latest Blog Entries...